General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-14 | 2024-06 | -0.15 | N/A | N/A | N/A |
2024-05-09 | 2024-03 | -0.17 | -0.08 | 0.09 | 52.94% |
2024-03-25 | 2023-12 | -0.17 | -0.07 | 0.1 | 58.82% |
2024-03-25 | 2023-12 | -0.17 | N/A | N/A | N/A |
2023-11-08 | 2023-09 | -0.16 | N/A | N/A | N/A |
2023-11-08 | 2023-09 | -0.16 | -0.11 | 0.05 | 31.25% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-04-30 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-23 | Stifel | Upgrade | Buy | |
2023-02-07 | SVB Leerink | Upgrade | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-10-15 | BIOCON SA | Beneficial Owner of more than 10% of a Class of Security | 2.32M | Stock Award(Grant) |
2021-10-05 | CONNELLY STEPHEN | Officer and Director | 993.00K | Sale |
2023-12-07 | KEYES JASON A | Chief Financial Officer | 136.63K | Stock Award(Grant) |
2023-12-07 | ROTHMAN JOEL | Officer | 58.15K | Stock Award(Grant) |
2023-12-07 | ZEDELMAYER CHRISTINE | Chief Operating Officer | 135.25K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Decheng Capital Management III (Cayman), LLC | 4.45M | 3.34M | 12.87% |
2023-06-29 | JP Morgan Chase & Company | 1.19M | 893.49K | 3.45% |
2023-06-29 | Franklin Resources, Inc. | 895.00K | 671.25K | 2.59% |
2023-06-29 | Vanguard Group Inc | 836.93K | 627.70K | 2.42% |
2023-06-29 | Cota Capital Management, Llc | 562.28K | 421.71K | 1.63% |
2023-06-29 | Tang Capital Management, LLC | 400.00K | 300.00K | 1.16% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 570.84K | 428.13K | 1.65% |
2023-07-30 | Franklin Strategic Series-Franklin Biotechnology Discove | 294.80K | 218.15K | 0.85% |
2023-06-29 | Vanguard Extended Market Index Fund | 242.41K | 181.81K | 0.70% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 123.50K | 92.63K | 0.36% |
2023-05-30 | Fidelity Extended Market Index Fund | 88.26K | 54.28K | 0.26% |
2023-05-30 | Fidelity Total Market Index Fund | 21.68K | 13.33K | 0.06% |
Regret for those who’ve waited. It is approved in India and expect nearby countries grabbed this since MRNA, NVAX and BNTX still raising.
By VBIV now as well and IBIO.. I already have the ALT and VXRT and making green paper already in addition to EQ. Go get yours too.
Wait for 18$ when it hits that #, there’s no turning back, this stock is a Beast! this is 2nd to the experience I had 4 years ago KBIO that Martin Shkreli is pumping up and was delisted after.
Get in quick! Adding another 10K.. lol
Volume is now moving, this will be very quick. I will be sleeping again tonight and when I wake up tomorrow morning this will be a lot of chais again like yesterday.
Wait when the Indians are awake, they are still sleeping because they got drunk yesterday’s gain. Lol
You better watch on this, if it Pours it Pours ! It is quick and crazy money. I got in at 8 yesterday, today I covered again for the one I sold at 25 yesterday.
10K added.. this will be awesome and NO Regrets!!! Lol
Get in guys, this is free money. This will be 35+ today
Tomorrow’s another story. This will be like NVAX and MRNA chase replicate.
I can smell 30$ tomorrow on this.
Hahahaha. Awesome Guys!! Love it!
Let’s see 12+. Bull!
EQ $8.50